Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 21 July 2020, 09:45 HKT/SGT
Share:
    

Source: NEC Corporation
BostonGene and NEC Collaborate to Analyze Cancer Patients in Clinical Trials
Integrated Genomic and Transcriptomic Next Generation Sequencing (NGS) Data to Reveal Cellular Content of Tumor Microenvironment

TOKYO, July 21, 2020 - (JCN Newswire) - BostonGene Corporation (BostonGene), a biomedical software company focused on defining optimal precision medicine-based therapies for cancer patients, and NEC Corporation (TSE: 6701), a leader in IT and network technologies, today announced a collaboration to conduct cancer patient analysis treated under NEC's clinical trials. This collaboration brings together NEC's artificial intelligence (AI)-driven approach to cancer immunotherapy with BostonGene's sophisticated analytical tools.

Under the terms of the collaboration agreement, BostonGene will perform tumor molecular profiling and microenvironment analysis for cancer patients identified in trials by NEC and or NEC affiliates across cancer types and disease stages. The collaboration aims to provide a molecular characterization of patient tumors for improvement of treatment response, both in clinical trial settings and beyond.

BostonGene's solution integrates next-generation sequencing (NGS) obtained from a patient's tumor with a reference cohort of data from patients with a similar diagnoses, simultaneously analyzing tumor and tumor microenvironment activity. The solution will identify all significant somatic alterations, protein expression, the activity of tumor-promoting and suppressing processes, tumor microenvironment cellular composition, tumor heterogeneity, tumor clonality, hereditary predisposition, viral infestation and pharmacogenomics among other molecular features.

"We are very excited to partner with NEC," said Andrew Feinberg, President and CEO at BostonGene. "The collaboration between NEC and BostonGene demonstrates the combined commitment to delivering truly breakthrough therapies that identify personalized, effective treatments to dramatically improve patients' chances for survival and quality of life."

"We are partnering with BostonGene because of its advanced patient analysis services," said Osamu Fujikawa, Senior Vice President at NEC Corporation. "The strategic collaboration with BostonGene is reflective of our mission to improve cancer patient outcomes. BostonGene's innovative data analytics platform combined with NEC's cutting-edge AI technology gives us the tools needed to focus on advancing treatment options for cancer patients."

About BostonGene Corporation

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene's unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene's mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies. For more information, visit BostonGene at new windowhttp://www.BostonGene.com.

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.


Topic: Press release summary
Source: NEC Corporation

Sectors: Enterprise IT, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


NEC Corporation Links

http://www.nec.com

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

NEC Corporation
Sept 30, 2025 18:52 HKT/SGT
Ouribank Signs Agreement with NEC to Implement AI-Native Data Center and Campus Network from HPE Juniper Networking for Enhanced Operational Efficiency
Sept 29, 2025 15:24 HKT/SGT
NEC Releases Third Edition of TNFD Report
Sept 26, 2025 20:20 HKT/SGT
NEC Launches 25Gb/s SFP28 Bi-directional Optical Transceiver Capable of 80km Transmission
Sept 24, 2025 13:43 HKT/SGT
Meta, SoftBank Corp., IPS, TM, XLSmart, and NEC to build the Candle Submarine Cable System, Intra Asia, 24-Fiber Pair Optical Submarine Cable, Connecting Japan to Singapore
Sept 19, 2025 18:00 HKT/SGT
MOTER Technologies and NEC Form Strategic Capital Alliance to Advance the Future of Mobility Through Digital Innovation
Sept 16, 2025 13:00 HKT/SGT
NEC Publishes ESG Initiatives Supporting Sustainable Growth of Companies and Society in "ESG Databook 2025"
Sept 12, 2025 14:08 HKT/SGT
The University of Osaka D3 Center Commences Operation of New Computing and Data Infrastructure Built by NEC
Sept 5, 2025 10:20 HKT/SGT
NEC participates in Locked Shields 2025 hosted by the NATO Cooperative Cyber Defence Centre of Excellence
Sept 4, 2025 10:15 HKT/SGT
NEC to begin proof of concept for early earthquake detection and analysis in Colombia
Aug 27, 2025 21:57 HKT/SGT
NEC develops AI technology for digitalizing work tasks without the need for pre-training and utilizing video from multiple cameras covering wide area worksites
More news >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: